Compound Detail
CHEMBL1732
DIHYDROERGOTAMINE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21
Basic Information
| ChEMBL ID | CHEMBL1732 |
| Name | DIHYDROERGOTAMINE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | LUZRJRNZXALNLM-JGRZULCMSA-N |
| Therapeutic | ✓ Yes |
25
Targets
50
Activities
4
Assay Types
1
PK Parameters
20
Publications
6
Known Names
3
Indications
Molecular Properties
583.7
MW (Da)
2.08
ALogP
6
HBA
3
HBD
118.2
PSA (Ų)
0.43
QED
1
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1946 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Indications
Migraine Disorders Migraine with Aura Migraine without Aura
ATC Classification
N02CA01
dihydroergotamine
Level 1: NERVOUS SYSTEM
Level 2: ANALGESICS
N02CA51
dihydroergotamine, combinations
Level 1: NERVOUS SYSTEM
Level 2: ANALGESICS
Activity Summary
IC50 26 meas. best 9.18
Ki 20 meas. best 9.42
Kd 3 meas. best 7.55
EC50 1 meas. best 5.19
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| 5-hydroxytryptamine receptor 1A CHEMBL273 | Ki | 9.42 | 9.42 | 0.4 | 1 |
| 5-hydroxytryptamine receptor 1B CHEMBL3459 | Ki | 9.42 | 9.42 | 0.4 | 1 |
| Alpha-2A adrenergic receptor CHEMBL1867 | Ki | 9.41 | 9.41 | 0.4 | 1 |
| 5-hydroxytryptamine receptor 1A CHEMBL273 | IC50 | 9.18 | 9.18 | 0.7 | 1 |
| 5-hydroxytryptamine receptor 1B CHEMBL3459 | IC50 | 9.07 | 9.07 | 0.8 | 1 |
| Alpha-2A adrenergic receptor CHEMBL1867 | IC50 | 8.99 | 8.99 | 1.0 | 1 |
| 5-hydroxytryptamine receptor 6 CHEMBL3371 | Ki | 8.83 | 8.83 | 1.5 | 1 |
| Alpha-2C adrenergic receptor CHEMBL1916 | Ki | 8.82 | 8.82 | 1.5 | 1 |
| Unchecked CHEMBL612545 | Ki | 8.78 | 7.06 | 1.7 | 2 |
| Alpha-2B adrenergic receptor CHEMBL1942 | Ki | 8.75 | 8.75 | 1.8 | 1 |
| D(3) dopamine receptor CHEMBL234 | Ki | 8.74 | 8.74 | 1.8 | 1 |
| Alpha-1A adrenergic receptor CHEMBL319 | Ki | 8.69 | 8.69 | 2.0 | 1 |
| 5-hydroxytryptamine receptor 2A CHEMBL224 | Ki | 8.64 | 8.64 | 2.3 | 1 |
| Unchecked CHEMBL612545 | IC50 | 8.6 | 6.95 | 2.5 | 2 |
| D(2) dopamine receptor CHEMBL217 | Ki | 8.53 | 8.53 | 3.0 | 1 |
| 5-hydroxytryptamine receptor 6 CHEMBL3371 | IC50 | 8.49 | 8.49 | 3.2 | 1 |
| 5-hydroxytryptamine receptor 2B CHEMBL1833 | Ki | 8.43 | 8.395 | 3.7 | 2 |
| Adrenergic receptor alpha-2 CHEMBL2093864 | IC50 | 8.43 | 8.43 | 3.7 | 1 |
| Alpha-2B adrenergic receptor CHEMBL1942 | IC50 | 8.41 | 8.41 | 3.9 | 1 |
| Alpha-1B adrenergic receptor CHEMBL315 | Ki | 8.35 | 8.35 | 4.5 | 1 |
| Alpha-1A adrenergic receptor CHEMBL319 | IC50 | 8.3 | 8.3 | 5.0 | 1 |
| D(3) dopamine receptor CHEMBL234 | IC50 | 8.27 | 8.27 | 5.3 | 1 |
| 5-hydroxytryptamine receptor 2B CHEMBL1833 | IC50 | 8.17 | 8.17 | 6.8 | 1 |
| 5-hydroxytryptamine receptor 2A CHEMBL224 | IC50 | 8.1 | 8.1 | 8.0 | 1 |
| Alpha-1B adrenergic receptor CHEMBL315 | IC50 | 8.09 | 8.09 | 8.1 | 1 |
| D(2) dopamine receptor CHEMBL217 | IC50 | 8.05 | 8.05 | 8.9 | 1 |
| Alpha-2C adrenergic receptor CHEMBL1916 | IC50 | 8.0 | 8.0 | 10.0 | 1 |
| Alpha-1D adrenergic receptor CHEMBL223 | Ki | 7.85 | 7.85 | 14.0 | 1 |
| Adrenergic receptor alpha-1 CHEMBL1907610 | IC50 | 7.57 | 7.57 | 27.0 | 1 |
| Adrenergic receptor alpha-1 CHEMBL2094251 | Kd | 7.55 | 7.55 | 28.2 | 1 |
| Alpha-1D adrenergic receptor CHEMBL223 | IC50 | 7.54 | 7.54 | 29.0 | 1 |
| 5-hydroxytryptamine receptor 2C CHEMBL225 | Ki | 7.33 | 7.33 | 47.0 | 1 |
| Adrenergic receptor alpha-2 CHEMBL2093864 | Kd | 7.25 | 7.25 | 56.2 | 1 |
| 5-hydroxytryptamine receptor 2C CHEMBL225 | IC50 | 7.05 | 7.05 | 90.0 | 1 |
| 5-hydroxytryptamine receptor 4 CHEMBL5017 | Ki | 6.8 | 6.8 | 157.0 | 1 |
| Adrenergic receptor alpha-1 CHEMBL1907610 | Kd | 6.68 | 6.68 | 208.9 | 1 |
| 5-hydroxytryptamine receptor 4 CHEMBL5017 | IC50 | 6.03 | 6.03 | 940.0 | 1 |
| D(1A) dopamine receptor CHEMBL2056 | Ki | 5.92 | 5.92 | 1197.0 | 1 |
| D(1A) dopamine receptor CHEMBL2056 | IC50 | 5.62 | 5.62 | 2395.0 | 1 |
| Multidrug and toxin extrusion protein 1 CHEMBL1743126 | IC50 | 5.55 | 5.55 | 2800.0 | 1 |
| Cytochrome P450 3A4 CHEMBL340 | IC50 | 5.52 | 5.41 | 2999.2 | 2 |
| Unchecked CHEMBL612545 | EC50 | 5.19 | 5.19 | 6440.0 | 1 |
| Multidrug and toxin extrusion protein 2 CHEMBL1743127 | IC50 | 4.9 | 4.9 | 12600.0 | 1 |
| Gastrin/cholecystokinin type B receptor CHEMBL2854 | IC50 | 4.64 | 4.64 | 23000.0 | 1 |
| Solute carrier family 22 member 2 CHEMBL1743122 | IC50 | 4.3 | 4.3 | 49900.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| T1/2 | 9.0 | hr | Mus musculus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.5281/zenodo.13943903 | ADMET | 29 |
| 22194678 | 10.1371/journal.pcbi.1002310 | Hepatotoxicity | 14 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-2A adrenergic receptor | 4 |
| 6142954 | 10.1021/jm00370a011 | Adrenergic receptor alpha-2 | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Muscarinic acetylcholine receptor M2 | 3 |
| 20014752 | 10.1021/tx900326k | Hepatotoxicity | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2B | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Cannabinoid receptor 1 | 3 |
| 6142954 | 10.1021/jm00370a011 | Adrenergic receptor alpha-1 | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-1A adrenergic receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | D(1A) dopamine receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Beta-2 adrenergic receptor | 2 |
| 6142954 | 10.1021/jm00370a011 | Adrenergic receptor alpha | 2 |
| 11961113 | 10.1124/mol.61.5.964 | ATP-dependent translocase ABCB1 | 2 |
| 12235267 | 10.1124/jpet.102.037549 | ATP-dependent translocase ABCB1 | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| 23241029 | 10.1021/jm301302s | Multidrug and toxin extrusion protein 1 | 2 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 2 |
| 24183589 | 10.1016/j.bmc.2013.09.022 | Unchecked | 2 |
| 26948801 | 10.1016/j.drudis.2016.02.015 | Homo sapiens | 2 |
Data from ChEMBL 36 via Core Engine